DrugPatentWatch Database Preview
« Back to Dashboard
The generic ingredient in LIPIODOL is ethiodized oil. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ethiodized oil profile page.
Generic Entry Opportunity Date for 009190
Generic Entry Date for 009190*:
Constraining patent/regulatory exclusivity:
SELECTIVE HEPATIC INTRA-ARTERIAL USE FOR IMAGING TUMORS IN ADULTS WITH KNOWN HEPATOCELLULAR CARCINOMA (HCC)
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||OIL;INTRALYMPHATIC, INTRAUTERINE||Strength||EQ 4.8GM IODINE/10ML (EQ 480MG IODINE/ML)|
|Approval Date:||Approved Prior to Jan 1, 1982||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Apr 4, 2021|
|Regulatory Exclusivity Use:||SELECTIVE HEPATIC INTRA-ARTERIAL USE FOR IMAGING TUMORS IN ADULTS WITH KNOWN HEPATOCELLULAR CARCINOMA (HCC)|
Complete Access Available with Subscription